Showing 41 - 60 results of 103,465 for search '(( 5 g decrease ) OR ( 5 ((((non decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.68s Refine Results
  1. 41

    CD34<sup>+</sup> cell populations decreased in malaria. by Carmen M. Dickinson-Copeland (824626)

    Published 2015
    “…(B) Circulating EPC numbers (CD45<sup>-</sup>CD34<sup>+</sup>VEGFR2<sup>+</sup>) are decreased in malaria patients by 1.7-fold compared with non-malaria. …”
  2. 42
  3. 43
  4. 44

    A decrease in cellular RNA increases the insolubility of TDP-43. by Shinnosuke Takagi (428655)

    Published 2013
    “…(C) Immunoblots of the immunoprecipitated protein with anti-V5 antibody or control IgG. (D) Reverse transcription-PCR (RT-PCR) of hNFL from immunoprecipitated RNA. …”
  5. 45

    Overexpression of FTH1P3 decreased the miR-224-5p expression. by Xiaoli Zheng (232806)

    Published 2017
    “…<p>(A) Elevated expression of FTH1P3 decreased the miR-224-5p expression in the MUM-2B cell. …”
  6. 46
  7. 47

    Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

    Published 2022
    “…<p><b>(</b>A and F) Representative immunoblots of hippocampal (A) and cortical (F) lysates of non-transgenic and 5XFAD mice treated with vehicle or nimodipine. …”
  8. 48
  9. 49
  10. 50
  11. 51
  12. 52

    Decreased axonal mitochondrial length in cultured 5xFAD mouse neurons. by Lu Wang (45927)

    Published 2016
    “…<p><b>(A)</b> 5xFAD mouse neurons demonstrated significantly decreased axonal mitochondrial length in comparison to nonTg neurons. …”
  13. 53
  14. 54
  15. 55
  16. 56
  17. 57
  18. 58
  19. 59
  20. 60

    Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

    Published 2022
    “…Specifically, compound <b>20g</b> displayed a 3.67-fold decrease of plasma AUC<sub>(tofacitinib, 0–∞)</sub> and a 9.61-fold increase of colonic AUC<sub>(tofacitinib, 0–12h)</sub>, compared with tofacitinib at a molar equivalent oral dose. …”